223 related articles for article (PubMed ID: 10706413)
1. In vitro biological activities of a series of 2 beta-substituted analogues of 1 alpha,25-dihydroxyvitamin D3.
Tsugawa N; Nakagawa K; Kurobe M; Ono Y; Kubodera N; Ozono K; Okano T
Biol Pharm Bull; 2000 Jan; 23(1):66-71. PubMed ID: 10706413
[TBL] [Abstract][Full Text] [Related]
2. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
[TBL] [Abstract][Full Text] [Related]
3. Biological activities of 2alpha-substituted analogues of 1alpha,25-dihydroxyvitamin D3 in transcriptional regulation and human promyelocytic leukemia (HL-60) cell proliferation and differentiation.
Takahashi E; Nakagawa K; Suhara Y; Kittaka A; Nihei K; Konno K; Takayama H; Ozono K; Okano T
Biol Pharm Bull; 2006 Nov; 29(11):2246-50. PubMed ID: 17077522
[TBL] [Abstract][Full Text] [Related]
4. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
Nakagawa K; Kurobe M; Ozono K; Konno K; Fujishima T; Takayama H; Okano T
Biochem Pharmacol; 2000 Mar; 59(6):691-702. PubMed ID: 10677586
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S
J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199
[TBL] [Abstract][Full Text] [Related]
6. Biological activity profiles of 1alpha,25-dihydroxyvitamin D2, D3, D4, D7, and 24-epi-1alpha,25-dihydroxyvitamin D2.
Tsugawa N; Nakagawa K; Kawamoto Y; Tachibana Y; Hayashi T; Ozono K; Okano T
Biol Pharm Bull; 1999 Apr; 22(4):371-7. PubMed ID: 10328556
[TBL] [Abstract][Full Text] [Related]
7. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
8. The 3-epi- and 24-oxo-derivatives of 1alpha,25 dihydroxyvitamin D(3) stimulate transcription through the vitamin D receptor.
Messerlian S; Gao X; St-Arnaud R
J Steroid Biochem Mol Biol; 2000; 72(1-2):29-34. PubMed ID: 10731635
[TBL] [Abstract][Full Text] [Related]
9. Co-chaperone potentiation of vitamin D receptor-mediated transactivation: a role for Bcl2-associated athanogene-1 as an intracellular-binding protein for 1,25-dihydroxyvitamin D3.
Chun RF; Gacad M; Nguyen L; Hewison M; Adams JS
J Mol Endocrinol; 2007 Aug; 39(2):81-9. PubMed ID: 17693608
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
11. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation.
Miura D; Norman AW; Mizwicki MT; Fujishima T; Konno K; Kittaka A; Takayama H; Ishizuka S
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):469-79. PubMed ID: 15876412
[TBL] [Abstract][Full Text] [Related]
12. Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells.
Schroeder NJ; Burrin JM; Noonan K; Makin HL; Cunningham J
Nephron Physiol; 2003; 94(4):p62-73. PubMed ID: 12972708
[TBL] [Abstract][Full Text] [Related]
13. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
14. Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathway.
Staal A; van den Bemd GJ; Birkenhäger JC; Pols HA; van Leeuwen JP
Bone; 1997 Mar; 20(3):237-43. PubMed ID: 9071474
[TBL] [Abstract][Full Text] [Related]
15. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
16. Syntheses and biological evaluation of novel 2alpha-substituted 1alpha,25-dihydroxyvitamin D3 analogues.
Suhara Y; Nihei KI; Tanigawa H; Fujishima T; Konno K; Nakagawa K; Okano T; Takayama H
Bioorg Med Chem Lett; 2000 May; 10(10):1129-32. PubMed ID: 10843234
[TBL] [Abstract][Full Text] [Related]
17. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D
Yasuda K; Tohyama E; Takano M; Kittaka A; Ohta M; Ikushiro S; Sakaki T
J Steroid Biochem Mol Biol; 2018 Apr; 178():333-339. PubMed ID: 29425808
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, metabolism, and biological activity of 2-[3-(tetrazolyl)propyl]-1α,25-dihydroxy-19-norvitamin D
Takano M; Yasuda K; Higuchi E; Tohyama E; Takeuchi A; Sakaki T; Kittaka A
J Steroid Biochem Mol Biol; 2016 Nov; 164():40-44. PubMed ID: 26232635
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
Chen ML; Ray S; Swamy N; Holick MF; Ray R
Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
